Digital Health Insights with Faegre Drinker explores the latest opportunities and challenges in our ever-changing industry. This learning forum allows attendees to access information on pressing issues directly from industry leaders and Faegre Drinker digital health professionals.
Questions? Please contact Kelley Stephens or call +1 317 237 1161.
Webinars in this Series
Session One (Friday, February 19, 2021) – The Role of the Federal Communications Commission (FCC)
The availability and deployment of digital health, telemedicine and telehealth often are influenced directly and indirectly by federal rules, regulations and funding from the United States Department of Health and Human Services (HHS). In recent years, however, the Federal Communications Commission (FCC) has exhibited a growing interest and role in telehealth and virtual care. In this first session, Dr. David Houghton of Ochsner Health, Ilisa Halpern Paul, Jodie Curtis and Laura Phillips will discuss the role of the FCC in supporting telehealth and digital medicine and the trends in FCC policy and funding.
- David Houghton, MD, MPH, System Chair of Telemedicine & Medical Director of Digital Medicine, Ochsner Health
- Jodie Curtis, Executive Vice President, District Policy Group, Faegre Drinker
- Ilisa Halpern Paul, MPP, President, District Policy Group, Faegre Drinker
- Laura Phillips, Telecommunications Partner, Faegre Drinker
Session Two (Wednesday, April 21, 2021) – Medical Device, Software and Patent Strategy
When we enter the digital health world, how do we adapt and establish a digital-aware patent strategy? In addition to changes in the healthcare industry, patent law is continuously evolving — especially in the software area. In this second session, Intellectual Property Owners Association Software Committee leaders and thought leadership collaborators Christina Huang and Christopher George will discuss the current state of patent law related to medical device software, pragmatic IP protection strategy, and practice tips.
- X. Christina Huang, Counsel, Faegre Drinker
- Christopher George, Intellectual Property Attorney, Hanley, Flight & Zimmerman
Session Three (Thursday, May 20, 2021) – Legal Pitfalls in Telemedicine Arrangements
In this session, attendees will understand the myriad of legal risks and pitfalls associated with providing telemedicine services and how to avoid them. Attendees will learn about compliance with the Stark Law and Anti-Kickback Statute regarding telemedicine, recent enforcement trends particularly related to the increased use of telemedicine during COVID, billing compliance risks, and risks related to the use of telemedicine platforms, including the corporate practice of medicine and fee splitting.
- Steve Lokensgard
Session Four (Thursday, July 22, 2021) – Artificial Intelligence in Health Care
Artificial intelligence (AI) and machine learning (ML) are transforming the health care industry and the ways in which patients receive medical care. As with any emerging technology, there are important ethical and legal considerations related to the design and implementation of AI/ML throughout each stage of the continuum of care. In this session, the presenters will explore these ethical and legal considerations and how technology and health care companies are working together to address these issues, and to develop industry standards for the use of AI in the health care industry.
- Jackie Haydock, Principal Corporate Counsel, Microsoft
- Kate Middleton, Associate, Faegre Drinker
Session Five (Monday, November 15, 2021) – Let’s Talk Telehealth and Online Pharmacy — Featuring hims & hers Chief Medical Officer Patrick Carroll
Increasingly, telehealth platforms are building, buying or contracting with third-party preferred pharmacies to offer patients a “one-stop-shop” health care experience. Participants will hear from Patrick Carroll, the chief medical officer for hims & hers, a company leading in this space, and Libby Baney, a Faegre Drinker partner in the government and regulatory affairs practice, to discuss business and consumer trends and legal developments relevant to both telehealth and pharmacy operations.
- Libby Baney, Partner, Faegre Drinker
- Dr. Patrick Carroll, Chief Medical Officer, hims & hers
Continuing Education Credit
This program has been approved only for the following continuing legal education credits:
- California – 1 participatory hour of general credit,
- Colorado – 1 live hour of general credit;
- Illinois – 1 hour of general credit;
- Indiana – 1 distance hour of substantive general credit;
- New Jersey – 1.2 distance hours of CLE Credit;
- New York – 1 non-traditional hour of professional practice credit for both newly admitted and experienced attorneys;
- Pennsylvania – 1 live hour of substantive law, practice, and procedure CLE credit; and
- Texas – 1 hour of general credit.
There are no mandatory continuing legal education (MCLE) requirements in Michigan, Maryland, Massachusetts or the District of Columbia and they do not approve programs for CLE credit nor are attendees required to attend programs for CLE credit. We will; however, provide attendees from these jurisdictions with a certificate of attendance confirming their attendance and the credits approved in the above MCLE jurisdictions. Both Florida and Hawaii allow attendees to self-request reciprocal credit for attendance at a program approved in another MCLE jurisdiction, we will provide attendees from these states with a multi-state certificate of attendance for them to do so.
Faegre Drinker Biddle & Reath LLP (Faegre Drinker) has been certified by the New York Continuing Legal Education Board, the Pennsylvania Continuing Legal Education Board, and the Illinois Minimum Continuing Legal Education Board as an Accredited Provider of continuing legal education. Faegre Drinker is a Certified Provider, as recognized by the Colorado Supreme Court Continuing Legal Judicial Education Committee and a State Bar of California approved MCLE provider. Faegre Drinker is an Approved Sponsor with the Indiana Commission for Continuing Legal Education and an accredited provider approved by the State Bar of Texas, Committee on MCLE.